Graduates of the Department of Pharmacology and Toxicology

Graduates of the Department of Pharmacology and Toxicology

#GraduateDegreeYearMentorDissertation/Thesis Title (electronic versions)

J. Caleb Greenwell

Ph.D.2017Jessie Roman, M.D.

Age-related host factors regulate lung cancer progression


Marcus W. Stepp

Ph.D.2017David W. Hein, Ph.D.

Role of human arylamine N-acetyltransferase 1 in tumorigenesis and cancer biology


Lauren G. Poole-Hardy

Ph.D.2017Gavin E. Arteel, Ph.D.

Novel insight into the liver-lung axis in alcohol-enhanced acute lung injury


Zimple D Kurlawala

Ph.D.2017Levi J. Beverly, Ph.D.

UBQLN1: A multi-domain protein with multiple functions


Tuo Shao

Ph.D.2017Wenke Feng, Ph.D.

The role of HIF-1α in intestinal epithelial barrier function in alcoholic liver disease


Laila Al-Eryani

Ph.D.2017J. Christopher States, Ph.D.

miRNA expression changes in arsenic-induced skin cancer in vitro and in vivo  


J. Mason Hoffman

M.S.2017J. Christopher States, Ph.D.

Targeting the major regulator of mitosis 


Ashley M. Mudd

M.S.2017Ramesh C. Gupta, Ph.D.

Prevention and treatment of familial adenomatous polyposis and colorectal cancer by bilberry-derived anthocyanidins


Divya Karukonda

M.S.2017Ramesh C. Gupta, Ph.D.

Advances in tumor-targeted therapy using nanomedicine


Rachel M. Speer

M.S.2017John P. Wise, Sr., Ph.D.

The comparative cytotoxicity and genotoxicity of hexavalent chromium in humans and sea turtles


Tess V. Dupre

Ph.D.2017Leah J. Siskind, Ph.D.

Sphingolipids in models of kidney injury and disease


Elizabeth M. Hollis

M.S.2017Ayman El-Baz, Ph.D.

Diffusion-weighted magnetic resonance imaging in diagnosing graft dysfunction: a non-invasive alternative to renal biopsies


Al Hassan Kyakulaga

M.S.2017Ramesh C. Gupta, Ph.D.

Withaferin A synergistically enhances the effect of paclitaxel against lung cancer

293Stephan L. WechmanPh.D.2017Kelly M. McMasters, M.D., Ph.D.

Characterization of a mutant oncolytic adenovirus and the role of JNK in enhancing virotherapy

292Nicole M. Jackson-SanterrePh.D.2017Brian P. Ceresa, Ph.D.

Identifying the signaling mechanisms of EGFR-mediated apoptosis

291Jaspreet S. GrewalPh.D.2017Jason A. Chesney, M.D., Ph.D.

Targeting the glucose metabolism of myeloid-derived suppressor cells (MDSCs) to stimulate cancer immunity

290Christine E. DolinM.S.2017Juliane I. Beier, Ph.D.

The effects of moderate alcohol consumption and inflammation on the hepatic matrisome and the renal cortex proteome

289Christopher P. ShidalPh.D.2017Keith R. Davis, Ph.D.

Combating malignant melanoma with the multifaceted soy-derived peptide lunasin

288Aaron M. NeelyPh.D.2017Chi Li, Ph.D.

The interaction of homoserine lactones and paraoxonase 2 modulates cell death signaling and cell proliferation

287Gretchen E. HolzM.S.2016Igor S. Lukashevich, M.D., Ph.D., D.Sc.

Proinflammatory cytokines promote viral replication and cell cycle mediators in arenavirus-induced hepatitis

286Glenn W. VicaryPh.D.2016Jesse Roman, M.D.The role of nicotine, α7 nicotinic acetylcholine receptors and extracellular matrix remodeling in pulmonary fibrosis
285Aditya S. BarveM.S.2016Levi J. Beverly, Ph.D.

Establishing a clinically relevant mouse model of human AML to test novel transmethylation inhibitors

284Kevin M. TyoM.S.2016Jill Steinbach-Rankins, Ph.D.

Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections

283Justin L. HallgrenPh.D.2016Michal Hetman, M.D., Ph.D.The role of the nucleolus in neurodegeneration
282Anna L. LangM.S.2016Juliane I. Beier, Ph.D.Vinyl chloride-diet interactions in liver disease: potential roles of autophagy and energy management
281Wei-Yang (Jeremy) ChenPh.D.2016Swati Joshi-Barve, Ph.D. & Craig McClain, M.D.Acrolein is a critical mediator of alcohol-induced liver and intestinal injury in alcoholic liver disease
280Jordan B. FinchM.S.2016Daniel J. Conklin, Ph.D.Air pollution, pulmonary oxidative stress, and the endothelin system in the development of cardiovascular injury
279Julie A. GosneyM.S.2016Brian P. Ceresa, Ph.D.Isolation of EGFR-containing early endosomes
278Cierra N. SharpM.S.2016Leah J. Siskind, Ph.D.Developing a more clinically-relevant mouse model of cisplatin-induced nephrotoxicity
277Dominique Z. JonesPh.D.2016La Creis R. Kidd, Ph.D. & Geoffrey J. Clark, Ph.D.

MicroRNA-186 and metastatic prostate cancer

276Diana V. AvilaPh.D.2016Shirish Barve, Ph.D. & Leila Gobejishvili, Ph.D.Role of phosphodiesterase-4 in alcohol-induced organ injury
275Aaron M. NeelyM.S.2016Chi Li, Ph.D.Modulation of cell death signaling and cell proliferation by the interaction of homoserine lactones and paraoxonase 2
274Hridgandh DondePh.D.2015Shirish Barve, Ph.D.Mechanisms and intervention strategies for alcohol and HIV-antiretroviral therapy-induced liver injury
273Keegan J. BaldaufPh.D.2015Nobuyuki Matoba, Ph.D.Studies on the impacts of a plant-made recombinant cholera toxin B subunit on the gastrointestinal tract
272Pritesh P. KumarPh.D.2015Zhao-Hui (Joe) Song, Ph.D.Searching for novel ligands for the cannabinoid and related receptors
271Zimple D. KurlawalaM.S.2015Levi J. Beverly, Ph.D.Regulation of receptor tyrosine kinases by UBQLN1
270Stephen L. WechmanM.S.2015Kelly M. McMasters, M.D., Ph.D.Improved oncolytic virotherapy by increasing virus spread within tumors
269Lauren G. PooleM.S.2015Gavin E. Arteel, Ph.D.Alcohol-enhanced acute lung injury: Role of plasminogen activator inhibitor-1 and the transitional extracellular matrix
268Harshulkumar M. PanditM.S.2015Robert C.G. Martin, II, M.D., Ph.D.Identifying hepatocellular carcinoma (HCC) cells with cancer stem cell-like properties
267Nicole M. JacksonM.S.2015Brian P. Ceresa, Ph.D.The regulation and mechanisms of EGFR-mediated apoptosis in MDA-MB-468 cells
266Tess V. DupreM.S.2015Leah J. Siskind, Ph.D.Identifying novel renoprotective strategies for cisplatin-induced AKI
265Samantha M. CarlisleM.S.2015David W. Hein, Ph.D.Investigating pathway changes associated with varying levels of human arylamine N-acetyltransferase 1 (NAT1) activity
264Tareq Al-MaqtariPh.D.2015Aruni Bhatnagar, Ph.D. & Kyung Hong, Ph.D.Promoting differentiation and survival of human c-kit+ cardiac progenitor cells ex vivo
263J. Caleb GreenwellM.S.2015Jesse Roman, M.D.Role of nicotinic acetylcholine receptors in lung cancer
262Veronica L. MasseyPh.D.2014Gavin E. Arteel, Ph.D.Extracellular matrix proteins and the liver-lung axis in disease
261Christopher G. EnglandPh.D.2014Hermann B. Frieboes, Ph.D.Study of novel nanoparticle transport and drug release for cancer treatment
260Banrida WahlangPh.D.2014Matthew C. Cave, M.D.Evaluating the effects of polychlorinated biphenyls in non-alcoholic fatty liver disease
259Christopher P. ShidalM.S.2014Keith R. Davis, Ph.D.Lunasin reduces the melanoma stem cell population in-vitro and inhibits tumor proliferation in-vivo
258Dominique Z. JonesM.S.2014La Creis R. Kidd, Ph.D.The role of inflammatory and immune response-related sequence variants and miR-186 in prostate cancer
257Diana V. AvilaM.S.2014Shirish Barve, Ph.D. & Leila Gobejishvili, Ph.D.Pathogenic role of PDE4 in the development of alcohol induced hepatic steatosis
256Wei-Yang (Jeremy) ChenM.S.2014Craig J. McClain, M.D.The pathogenic role of acrolein in alcoholic liver disease
255Marcus W. SteppM.S.2014David W. Hein, Ph.D.Inducible tumor difference between rapid and slow rat Nat2 congenic Fischer 344 rats administered methyl-nitrosourea
254Morgan L. StathemM.S.2014Levi J. Beverly, Ph.D. & Leah J. Siskind, Ph.D.Building a metabolic bridge between glycolysis and sphingolipid biosynthesis: Implications for cancer
253Christopher L. BartonPh.D.2014Kenneth E. Palmer, Ph.D.Evaluation of the safety and pharmacokinetic profile of the broad spectrum antiviral lectin griffithsin
252Ryan C. McAllisterM.S.2014Colleen B. Jonsson, Ph.D.Development of models for the study of the molecular mechanisms of host restriction and adaptation of hantaviruses
251Zachary J. PritchardM.S.2014Uma Sankar, Ph.D.Bone strength and architecture: pharmacological targeting of CaMKK2 as a method for enhancing bone quality
250Laila Al-EryaniM.S.2014Matthew C. Cave, M.D.The role of pesticides in non-alcoholic fatty liver disease (NAFLD)
249Melissa E. SkibbaM.S.2014Lu Cai, M.D., Ph.D.Preventive effect of non-mitogenic acidic fibroblast growth factor on diabetes-induced testicular cell death
248Justin L. HallgrenM.S.2014Michal Hetman, M.D., Ph.D.The role of the nucleolus in neurodegeneration
247Pei-Hsin (Penny) ChengPh.D.2013Kelly M. McMasters, M.D., Ph.D.Cyclin E induction and oncolytic replication of E1B-deleted adenoviruses
246Amanda B. LasnikM.S.2013Kenneth E. Palmer, Ph.D.Preclinical safety assessment of griffithsin-based vaginal microbicides
245Alex C. BelshoffPh.D.2013Teresa Fan, Ph.D.Probing the anti-cancer mechanism of selenite: a metabolic approach
244Robin H. SchmidtPh.D.2013Gavin E. Arteel, Ph.D.Olanzapine-induced liver injury: Direct metabolic effects, exacerbation by high-fat diet, and protection with sulforaphane
243Christopher G. EnglandM.S.2013Hermann B. Frieboes, Ph.D.Optimization of drug uptake into solid tumors using an integrated experimental/computational modeling approach
242Glenn W. VicaryM.S.2013Jesse Roman, M.D.The role of α7 nicotinic acetylcholine receptors in lung injury and repair
241Hridgandh DondeM.S.2013Shirish Barve, Ph.D.Role of ethanol as a cofactor in HAART induced hepatic steatosis and injury
240Veronica L. MasseyM.S.2012Gavin E. Arteel, Ph.D.Integrin inhibitor cyclorgdfv blunts enhanced LPS-induced liver injury caused by ethanol in mice
239Keegan J. BaldaufM.S.2012Gavin E. Arteel, Ph.D.Acetaldehyde dehydrogenase 2 (ALDH2) activation protects hepatocytes from mitochondrial damage and death caused by 4-hydroxynonenal
238Madhuvanti PatilPh.D.2012Shirish Barve, Ph.D.The role of the transmethylation pathway in the regulation of cell death in leukemic CD4+ T cells
237Colins O. EnoPh.D.2012Chi Li, Ph.D.The role of endogenous Bcl-xL in regulation of apoptotic signaling pathways
236Akshata MoghePh.D.2012Shirish Barve, Ph.D.Role of chromatin remodeling in curcumin-mediated regulation of gene expression in hepatocellular carcinoma
235Carmine S. LeggettPh.D.2012David W. Hein, Ph.D.Role of human arylamine N-acetyltransferase in carcinogen metabolism and human breast cancer progression
234Daniel FioretM.S.2012Jesse Roman, M.D.Idiopathic pulmonary fibrosis: Diagnosis, management, and the search for a cure
233Tareq Al-MaqtariM.S.2012Uma Sankar, Ph.D.Approaches in the treatment of Parkinson's disease: A focus on stem cell-based therapies
232Banrida WahlangM.S.2012Matthew Cave, M.D.Polychlorinated biphenyl 153 exacerbates nonalcoholic fatty liver disease in C57BL/6 mice
231Huihui WuM.S.2012Al Cunningham, Ph.D.Structure-activity relationship model for estrogen receptor ligands
230Elaina Marie ChambersPh.D.2012Shirish Barve, Ph.D.The role of phosphodiesterase 4 in diabetic inflammation
229Pritesh P. KumarM.S.2011Zhao-Hui (Joe) Song, Ph.D.Searching for novel ligands for cannabinoid and related receptors
228Benjamin M. RisnerM.S.2011Richard Goldstein, M.D., Ph.D.Pharmacists as mid-level healthcare providers and the clinical results of a pharmacist-led diabetes disease management program
227Stephanie A. MathewsPh.D.2011Shirish Barve, Ph.D.Role of HDACs and SAM in interferon-alpha signaling and epigenetic regulation of anti-HCV gene expression
226Erica N. RogersPh.D.2011J. Christopher States, Ph.D.The role of curcumin in response to BPDE-induced DNA damage in human lung epithelial cells
225Katherine S. BourcyPh.D.2011Y. James Kang, Ph.D.Mechanistic insights into copper-induced regression of heart hypertrophy
224Ntube Nini Olive NgalamePh.D.2011J. Christopher States, Ph.D.Arsenic-induced developmental changes in the liver and adult cardiovascular disease
223Shelia A. ArnoldPh.D.2011Theo Hagg, M.D., Ph.D.Roles of 5HT1A receptor in CNS neurogenesis and ADAM21 in spinal cord injury
222Clarisse S. MuenyiPh.D.2011J. Christopher States, Ph.D.Mitigating cisplatin resistance in ovarian cancer
221Lori M. MillnerPh.D.2011David W. Hein, Ph.D.Functional analysis of N-acetyltransferase (NAT1*14B and NAT1*10) in complete NATb and NATa mRNA
220Pei-Hsin (Penny) ChengM.S.2011Kelly M. McMasters, M.D., Ph.D.Adenovirus-induced cyclin E activates CDK2 for virus replication
219Lindsey Jay StallonsPh.D.2011J. Christopher States, Ph.D.DNA polymerase iota promotes G2/M checkpoint activation and genetic stability after UV-induced DNA damage
218Shyam Sunder BansalPh.D.2011Ramesh C. Gupta, Ph.D.Development and evaluation of polymeric implants of curcumin for enhanced chemopreventive activity
217Christopher L. BartonM.S.2011Kenneth E. Palmer, Ph.D.Profile of systemic treatment with the antiviral lectin griffithsin in guinea pigs
216Pengxiao CaoPh.D.2011Ramesh C. Gupta, Ph.D.Prevention and treatment of lung cancer by green tea polyphenols
215Gilandra K. RussellPh.D.2011Ramesh C. Gupta, Ph.D.Sustained systemic delivery of chemopreventive agents in inhibiting dibenzo[a,l]pyrene-induced DNA adducts in the lungs of A/J mice
214Jianxun WangPh.D.2011Paul N. Epstein, Ph.D.Cardiac abnormalities after transaortic constriction are worsened by changing glucose metabolism and benefited by repair of mitochondrial DNA
213Robin H. SchmidtM.S.2011Gavin E. Arteel, Ph.D.Sulforaphane prevents acetaminophen-induced hepatic injury in mice
212Nicole A. LavenderPh.D.2010La Creis R. Kidd, Ph.D.The role of genetic and environmental oxidative stress factors in prostate cancer
211Lu YangPh.D.2010Paul N. Epstein, Ph.D.Adriamycin nephrotoxicity is reduced by metallothionein over-expression and kidney gene expression is modified by diabetes in the OVE26 diabetic model
210Afsoon MoktarPh.D.2010Ramesh C. Gupta, Ph.D.Cigarette smoke, DNA damage and repair in human cervical and vaginal cells in vitro and ex vivo
209Carmine S. LeggettM.S.2010David W. Hein, Ph.D.Effects of CYP1A2, NAT1, and NAT2 genetic variants in nucleotide excision repair-deficient human fibroblasts: Implications for toxicological risk from environmental arylamines
208Matthew R. ZajackM.S.2010J. Christopher States, Ph.D.Arsenic in drinking water causes gene expression changes in the liver related to inflammation and metabolic dysfunction and accelerates atherosclerosis in APOE-/- mice
207Akshata MogheM.S.2010Shirish Barve, Ph.D.Curcumin reactivates epigenetically silenced tumor suppressor gene tissue factor pathway inhibitor-2 in hepatocellular carcinoma cells
206Madhuvanti PatilM.S.2010Shirish Barve, Ph.D.Role of the transmethylation pathway in the regulation of cell death in T leukemic cells
205Colins O. EnoM.S.2010Chi Li, Ph.D.Mechanism of regulation of apoptosis by the BCL-2 proteins BCL-XL and BCL-XS
204Christelle K. KamgaPh.D.2010Yang Wang, M.D., Ph.D.GSH transport through the dicarboxylate carrier: A key component in UCP4-mediated antioxidants effects in neuronal-like PC12 cells
203John PhiliposePh.D.2010Michele Pisano, Ph.D.Craniofacial anomalies: sensitivity of the neural crest to altered folate metabolism
202Aisha Isabelle BagshawM.S.2010Aruni Bhatnagar, Ph.D.Potential cardiotoxic impact of aldehydes in the progression of atherosclerosis
201LaSharon D. MosleyPh.D.2009James W. Lillard, Jr., Ph.D.Mechanisms mediated by CXCL12 signaling through CXCR4 and CXCR7 in breast cancer
200J. Phillip KaiserPh.D.2009Gavin E. Arteel, Ph.D.The role of PKC-epsilon in models of alcohol- and toxin-induced liver disease
199Ntube Nini Olive NgalameM.S.2009J. Christopher States, Ph.D.Arsenic-induced developmental changes in the liver and adult cardiovascular disease
198Pengxiao CaoM.S.2009Ramesh C. Gupta, Ph.D.Effect of green tea catehins and hydrolyzable tannins on benzo[a]pyrene-induced DNA adducts and structure activity relationship
197Shyam Sunder BansalM.S.2009Ramesh C. Gupta, Ph.D.A novel implantable drug delivery system of curcumin for cancer chemoprevention
196Jean-Claude NzimulindaPh.D.2009Zhao-Hui (Joe) Song, Ph.D.Ligand binding, activation, and dimerization of CB2 cannabinoid receptor
195Yang ZhouPh.D.2008Y. James Kang, Ph.D.Copper-induced regression of cardiomyocyte hypertrophy through alteration of VEGF/VEGFR pathways
194Nason P. SchoolerM.S.2008John W. Eaton, Ph.D.The use of the reducing agent N-(2-mercaptopropionyl)glycine to detoxify oxidized lipids in atherosclerotic lesions
193Katharine Shumate RichardsonPh.D.2008Wayne Zundel, Ph.D.Regulation of placental ribonuclease inhibitor by tumor suppressor Von Hippel-Lindau
192Stephanie A. MathewsM.S.2008Shirish Barve, Ph.D.Impaired SAM metabolism and IFNα antiviral signaling: Relevance to hepatitis C virus
191Robert C.G. Martin, IIPh.D.2008David W. Hein, Ph.D.Polymorphisms in manganese superoxide dismutase as a risk factor for cancer
190Nicole A. LavenderM.S.2008La Creis R. Kidd, Ph.D.Joint modifying effects of variant oxidative stress factors in relation to prostate cancer
189Emily Roberts EspositoPh.D.2008Michele Pisano, Ph.D.In vivo and in vitro models for cigarette smoke-induced low birth weight and other adverse developmental outcomes
188Christina Blume ClarkPh.D.2008Evelyne Gozal, Ph.D.The role of HSP90 in PC-12 cell survival
187Elaina Marie ChambersM.S.2008Shirish Barve, Ph.D.Immune dysregulation and diabetes: A potential role of phosphodiesterases
186Thomas J. SchlierfM.S.2008David W. Hein, Ph.D.Role of N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in breast cancer risk with exposure to aromatic and heterocyclic amine carcinogens
185Katherine S. BourcyM.S.2008Y. James Kang, Ph.D.The role of vascular endothelial growth factor receptors in copper-induced regression of cardiac hypertrophy
184Carl Alexander CarrasquerPh.D.2008Zhao-Hui (Joe) Song, Ph.D.Activation and regulation of cannabinoid receptors
183Clarisse S, MuenyiM.S.2008J. Christopher States, Ph.D.Improving the efficacy of platinum chemotherapy against ovarian cancer
182Lindsey Jay StallonsM.S.2008W. Glenn McGregor, M.D.Mutagenic and tumor suppressor functions of DNA polymerase iota in mammalian cells
181Lori M. MillnerM.S.2008David W. Hein, Ph.D.Effect of N-acetyltransferase (NAT1) polymorphism on mutagenesis and DNA adduct formation
180Shankang MaM.S.2008Y. James Kang, Ph.D.Metallothionein gene therapy for chemically-induced liver fibrosis
179Jean-Claude NzimulindaM.S.2008Zhao-Hui (Joe) Song, Ph.D.Residues accessible in the binding site crevice of transmembrane helix 2 of CB2 cannabinoid receptor
178Erica N. RogersM.S.2008J. Christopher States, Ph.D.The modulation of DNA damage by curcumin
177Nicholas B.  WatsonPh.D.2008W. Glenn McGregor, M.D.RAD18 is recruited to stalled DNA replication forks and is required for recruitment of accessory translesion synthesis proteins
176Xiaoyan (Susan) ZhangPh.D.2008David W. Hein, Ph.D.Characterization of N-acetyltransferase 1 (NAT1) expression in breast cancer
175Ya Fatou NjiePh.D.2007Zhao-Hui (Joe) Song, Ph.D.Cannabinoids as potential therapeutic agents for glaucoma
174Christelle K. KamgaM.S.2007Yang Wang, M.D., Ph.D.UCP4 is a key regulator of mitochondrial antioxidant defense in rat PC12 cells
173Jianxun WangM.S.2007Paul N. Epstein, Ph.D.The changes of fructos-2,6-biphosphate level in transgenic mice causing cardiomyopathy
172Joshua M. ThornburgPh.D.2007Jason A. Chesney, M.D., Ph.D.Identification of aspartate aminotransferase as a novel target for anti-neoplastic research
171Samuel C. McNeelyPh.D.2007J. Christopher States, Ph.D.Sensitivity to sodium arsenite depends upon susceptibility to mitotic arrest-associated apoptosis
170Jason M. WalravenPh.D.2007David W. Hein, Ph.D.Computational and functional analyses of human and rat N-acetyltransferase genetic variants N-acetyltransferase genetic variants
169J. Phillip KaiserM.S.2007Gavin E. Arteel, Ph.D.The role of PKC-epsilon in alcoholic liver disease
168Agata M. HabasPh.D.2007Michal Hetman, M.D., Ph.D.The role of GSK3β  and NFATc4 in NMDA-mediated neuronal survival
167B. Frazier TaylorPh.D.2007J. Christopher States, Ph.D.Arsenite inhibition of mitotic progression
166LaSharon D. MosleyM.S.2007Richard E. Goldstein, M.D., Ph.D.Estrogen receptors in thyroid cell proliferation
165Lu YangM.S.2007Paul N. Epstein, Ph.D.Protection by metallothionein from adriamycin induced nephropathy in mice and gene expression profiling during progression of diabetic nephropathy
164Chad A. DumstorfPh.D.2007W. Glenn McGregor, M.D.Participation of mouse DNA polymerases iota, eta, and rev1 in translesion synthesis of carcinogen induced DNA adducts and carcinogenesis
163Kristin J. MetryPh.D.2007David W. Hein, Ph.D.Role of N-acetyltransferase 2 polymorphism in DNA adduct formation and mutagenesis by aromatic and heterocyclic amine carcinogens
162Jin LiuPh.D.2007Michael E. Brier, Ph.D.Design evaluation for pharmacokinetic studies in patients with renal impairment
161Kevyn E. MertenPh.D.2007Y. James Kang, Ph.D.Effect of zinc on doxorubicin-induced activation of the calcineurin signaling pathway and the relation to myocardial cell death and hypertrophy
160Alex CarrasquerM.S.2006Zhao-Hui (Joe) Song, Ph.D.The effects of polymorphisms on the function of the CB2 cannabinoid receptor
159Afsoon MoktarM.S.2006Ramesh C. Gupta, Ph.D.Cigarette smoking as a major cofactor in human cervical cancer
158Emily Roberts EspositoM.S.2006M. Michele Pisano, Ph.D.Low birth weight-Consequences of maternal tobacco smoke exposure during embryonic and fetal development
157Nstang Miranda NebanePh.D.2006Zhao-Hui (Joe) Song, Ph.D.Structure-activity relationship of the CB1 and CB2 cannabinoid receptors
156Yang ZhouM.S.2006Y. James Kang, Ph.D.Copper inhibition of hydrogen peroxide-induced hypertrophy in H9C2 embryonic rat cardiac cells
155Xiaoqiang (Steven) XuM.S.2006Theresa Whei-Mei Fan, Ph.D.TrxR SECIS RNA synthesis and biophysical characterization
154Rundong (Ray) ZhangPh.D.2006Zhao-Hui (Joe) Song, Ph.D.Structure and function of CB2 cannabinoid receptors
153Sheila A. MullinsM.S.2006Paul N. Epstein, Ph.D.Effects of fructose-2,6-bisphosphate on Akt phosporylation and insulin signaling in cardiomyocytes
152Joshua M. ThornburgM.S.2006Jason A. Chesney, M.D., Ph.D.Role of lactate dehydrogenase A (LDH-A) in oncogenic transformation; Revisiting a classic enzyme
151Wei (Wendy) Yuan ChangPh.D.2006Theresa S. Chen, Ph.D.Mechanism of 4-hydroxynonenal induced toxicity in Jurkat CD4+ T lymphocytes
150Katharine S. RichardsonM.S.2006Wayne S. Zundel, Ph.D.Impact of von Hippel-Lindau in regulating ribonuclease activity in renal cell carcinoma
149Yu (Janet) ZangPh.D.2006David W. Hein, Ph.D.Functional characterization and mechanistic studies on single nucleotide polymorphisms of human N-acetyltransferase 2
148Tanvi S. JaniPh.D.2006Shirish Barve, Ph.D.Role of methionine adenosyltransferase II (MAT II) and S-adenosylmethionine (SAMe) in survival of CD4+ T lymphocytes: Relevance to immune dysfunction
147Stephen R. ReevesPh.D.2006David Gozal, M.D.Chronic intermittent hypoxia and respiratory plasticity
146Paul C. PorterPh.D.2005J. Christopher States, Ph.D.Discovery and functional analysis of XPA polymorphisms and use of telomerase immortalized cells for nucleotide excision repair studies
145Ya Fatou NjieM.S.2005Zhao-Hui (Joe) Song, Ph.D.Effects of the endogenous cannabinoid, noladin ether on aqueous humor outflow facility mediated by the CB1 cannabinoid receptor
144Molly Anne DavisM.S.2005Gavin E. Arteel, Ph.D.Characterization of recovery from liver damage by choline deficiency:  Effect of biochemical modulators of lipid metabolism?
143E. Cristian CampianPh.D.2005Frederick W. Benz, Ph.D.Acute acrylonitrile toxicity:  Mechanistic Studies
142Anwar HusainPh.D.2005David W. Hein, Ph.D.Regulatory control regions of human arylamine N-acetyltransferase 1 and 2:  Implications for genetic predisposition to breast cancer
141Xiaoyan (Susan) ZhangM.S.2005David W. Hein, Ph.D.Role of N-acetyltransferase (NAT) polymorphism on 4,4’-methylene bis (2-chloroaniline) and 4,4’-methylenedianiline (MDA) acetylation, MDA hepatotoxicity and a proposal to study NAT expression in breast cancer
140Gilandra K. RussellM.S.2005Gavin E. Arteel, Ph.D.Protection of cultured hepatocytes from hypoxic death by ATP-delivery with lipid vesicles
139Samuel C. McNeelyM.S.2005J. Christopher States, Ph.D.Arsenic:  A potential chemotherapeutic for melanoma
138Tanvi S. JaniM.S.2005Shirish Barve, Ph.D.Methionine adenosyltransferase IIA (MAT IIA) and S-adenosylmethionine (SAMe) are critical for the survival of CD4+ T lymphocytes
137Jin LiuM.S.2005Michael E. Brier, Ph.D.An evaluation of pharmacokinetic study design for describing drug disposition in renal failure
136Kevyn E. MertenM.S.2005Y. James Kang, Ph.D.Molecular mechanisms of metallothionein protection from adriamycin cardiotoxicity
135Jason M. WalravenM.S.2005David W. Hein, Ph.D.Investigations of N-acetyltransferases in human hepatocytes and rat models
134Nicholas B. WatsonM.S.2005W. Glenn McGregor, M.D.The ubiquitin ligase RAD18 is implicated in mutagenic translesion synthesis of DNA damage in human cells
133Prachi T. HoteM.S.2004Shirish Barve, Ph.D.Ethanol mediated loss of MAT2A (methionine adenosylmethyltransferase) expression and SAMe (S-adenosylmethionine) biosynthesis induced FAS-mediated CD4+ T lymphocyte death: Potential mechanism(s) for alcohol mediated immunotoxicity
132Ntsang Miranda NebaneM.S.2004Zhao-Hui (Joe) Song, Ph.D.Effects of D3.49N mutations on ligand binding and activation of the CB1 and CB2 cannabinoid receptors
131Xia (Clare) ShenPh.D.2004Paul N. Epstein, Ph.D.Mitochondrial damage and biogenesis in diabetic heart and protection by overexpression of manganese superoxide dismutase
130Chad A. DumstorfM.S.2004W. Glenn McGregor, M.D.Mutagenesis of induced tumors in murine lung
129Yuanqi ZhuPh.D.2004David W. Hein, Ph.D.Human NAT1 genetic polymorphisms: coding region & non-coding region
128Agata M. HabasM.S.2004Michal Hetman, M.D., Ph.D.The role of nuclear factors of activated T-cells (NFAT) in neuronal death
127Yu (Cindy) WangM.S.2004David Gozal, M.D.Cooperative effects of amyloid beta (25-35) and hypoxia-reoxygenation on cell death in primary cultured mouse neurons of cerebral cortex
126Christopher R. CunninghamPh.D.2004Steven R. Myers, Ph.D.Hemoglobin adducts and the role of genotype in the modification of risk associated with tobacco smoke exposure to the fetus
125Xiaoyan (Nina) LiPh.D.2004Paul N. Epstein, Ph.D.The roles of pancreatic beta cell antioxidants in islet transplantation and type 1 diabetes
124Kristin J. MetryM.S.2004David W. Hein, Ph.D.NAT polymorphism in breast cancer risk
123Wei (Wendy) Yuan ChangM.S.2004Theresa S. Chen, Ph.D.Mechanism of oxidative stress induced cell toxicity
122Jennifer A. LoehleM.S.2004David W. Hein, Ph.D.Pediatric pharmacogenetic studies:  The advent of genomics, clinical implications and current initiatives in research
121April K. HartfordPh.D.2004Nicholas A. Delamere, Ph.D.NA,K-ATPase Alpha 2: Its role in calcium homeostasis, signaling and cell survival in astrocytes
120Laila ElsherifPh.D.2004Y. James Kang, Ph.D.Dietary copper restriction-induced cardiomyopathy and its reversibility in mice
119Jian LiPh.D.2003John W. Eaton, Ph.D.Oxygen toxicity and mitochondrial metabolism
118Yu (Janet) ZangM.S.2003David W. Hein, Ph.D.Mechanistic studies on the T341C (Ile114Thr) single nucleotide polymorphism of human N-acetyltransferase 2
117Rundong (Ray) ZhangM.S.2003Zhao-Hui (Joe) Song, Ph.D.Cysteine 89(2.69) in the second transmembrane domain of human CB2 receptor is exposed in the ligand binding crevice
116Hainan ChenPh.D.2003Paul N. Epstein, Ph.D.Studies on the effects of pancreatic beta cell antioxidant transgenes on experimental models of diabetes
115Terry L. Wright, Jr.M.S.2003Gavin E. Arteel, Ph.D.The TNFalpha paradox in ischemic heart disease
114Denise R. ClarkM.S.2003W. Glenn McGregor, M.D.Ribozyme-mediated REV1L inhibition reduces UV-induced mutations in the human HPRT gene
113Paul C. PorterM.S.2003J. Christopher States, Ph.D.Detection and functional analysis of polymorphic XPA alleles
112Jason C. LambertPh.D.2003Y. James Kang, Ph.D.Zinc inhibition of acute ethanol-induced liver injury
111Yuanqi ZhuM.S.2002David W. Hein, Ph.D.Functional characterization of NAT gene polymorphisms
110Xiaoyan (Nina) LiM.S.2002Paul N. Epstein, Ph.D.Metallotheionein overexpression prolongs grafts survival in the early phase of pancreatic islet transplantation
109Bradley G. BrewerM.S.2002Peter P. Rowell, Ph.D.Short-term distribution of nicotine in the rat
108Xia (Clare) ShenM.S.2002Paul N. Epstein, Ph.D.Proteomics and morphology demonstrate mitochondrial changes in diabetic cardiomyopathy
107Hana H. KhaledM.S.2002William M. Pierce Jr., Ph.D.Osteoporosis: An overview of prevention, genetics, and treatment
106Hainan ChenM.S.2002Paul N. Epstein, Ph.D.Metallothionein protection against streptozotocin induced pancreatic beta cell damage and diabetes
105Jason R. NealePh.D.2002William M. Pierce Jr., Ph.D.Bone-targeted estrogens:  Structure-activity relationships and mechanistic studies
104Jian LiM.S.2002John W. Eaton, Ph.D.Mitochondrial metabolism and oxygen toxicity
103Yining HouPh.D.2002Nicholas A. Delamere, Ph.D.The influence of cytoplasmic calcium on H+-ATPase; and the influence of H+-ATPase inhibition on sodium transport in non-pigmented ciliary epithelial cells
102Alfred A. Jacobs, Jr.Ph.D.2001Michael E. Brier, Ph.D.Influence of cyclosporin on renal hemodynamics in the isolated perfused kidney
101Jason C. LambertM.S.2001Y. James Kang, Ph.D.Zinc inhibition of caspase-3 activation does not prevent apoptotic cell death
100E. Cristian CampianM.S.2001Frederick W. Benz, Ph.D.Acute acrylonitrile toxicity: inhibition of glyceraldehyde- 3-phosphate dehydrogenase activity in vitro
99Laila ElsherifM.S.2001Y. James Kang, Ph.D.Metallothionein protection against cadmium cardiotoxicity
98R. Scot PaynePh.D.2001Avital Schurr, Ph.D.The corticosterone hypothesis of hyperglycemia-enhanced cerebral ischemic damage
97Xin FuPh.D.2001Walter M. Williams, M.D., Ph.D.Para-Aminophenol-induced hepatotoxicity in hamsters
96Xichun SunPh.D.2001Y. James Kang, Ph.D.Metallothionein protection of the heart from ischemia/reperfusion injury: Cellular and molecular mechanisms
95John P. HennionM.S.2001Rif El-Mallakh, M.D.Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage
94April K. HartfordM.S.2000Nicholas A. Delamere, Ph.D.Calcium signaling in astrocytes of the optic nerve head; Evidence for a role for Na,K-ATPase Alpha-2
93Jason R. NealeM.S.2000William M. Pierce Jr., Ph.D.A novel bone selective estrogen:  A candidate compound for the treatment of osteopenia
92Adrian J. FretlandPh.D.2000David W. Hein, Ph.D.Pharmacogenetics of heterocyclic amine carcinogenesis
91Joseph A. Spinnato, IIIPh.D.1999Steven R. Myers, Ph.DMicrosomal metabolism and tissue distribution of N-Methyl-N-2,4,6-tetranitroaniline (tetryl)
90Matthew A. LeffPh.D.1999David W. Hein, Ph.D.Molecular genetics of N-acetyltransferases and prostate cancer
89Jian CaiPh.D.1999Harrell E. Hurst, Ph.D.N-(carboxymethyl)valine adduct in hemoglobin: A biomarker of advanced glycation end product formation and oxidative stress
88Jungyu LiPh.D.1999Frederick W. Benz, Ph.D.Acrylonitrile acute intoxication: Toxicodynamics and the effects of antidotes
87Nicolas MeloM.S.1999Walter M. Williams, M.D., Ph.D.Prevention of acetaminophen-induced hepatotoxicity by S-(2-hydroxyethylmercapto)-L-cysteine
86David A. HasselbacherM.S.1998George R. Aronoff, M.D.The development of a dosing model for the anticoagulant heparin using neural networks
85Emiko Lynn KreklauPh.D.1997Y. James Kang, Ph.D.Cross-resistance to adriamycin in cadium-resistant human lung carcinoma A549 cells
84Qiang WuPh.D.1997Nicholas A. Delamere, Ph.D.Studies of carbonic anhydrases and intracellular pH regulation in non-pigmented ciliary epithelial cells
83Mary Manlei LiPh.D.1997Avital Schurr, Ph.D.Global cerebral ischemia and neuroprotection
82Sue HanPh.D.1997Laurence A. Carr, Ph.D.Regulation of the dopamine neuronal transporter in the striatum
81Chandrika SrinivasanPh.D.1997Theresa S. Chen, Ph.D.Prevention of acetylaminophen-induced toxicity by n-propylthiazolidine carboxylic acid
80Yining HouM.S.1997Nicholas A. Delamere, Ph.D.Solutes transport mechanism in nonpigmented ciliary epithelium: influence of ascorbic acid uptake on sodium transport
79Maureen LiPh.D.1996Peter P. Rowell, Ph.D.Effect of chronic nicotine treatment on rat brain nicotine acetylcholine receptors
78Ray KemperPh.D.1995Harrell E. Hurst, Ph.D.Effects of xenobiotic induction in metabolic activation and detoxification of ethyl carbamate
77Hong SongPh.D.1994Theresa S. Chen, Ph.D.Mouse and rat differences in p-aminophenol-induced liver and kidney toxicities
76Jing DongPh.D.1994Nicholas A. Delamere, Ph.D.Solute transport mechanism in non-pigmented ciliary epithelium
75Yun MengPh.D.1994Walter M. Williams, M.D., Ph.D.Elimination of uridine, thymidine and thymine by the isolated perfused rat liver
74David B. GazakPh.D.1993Walter M. Williams, M.D., Ph.D.Pharmacological modulation of hepatic pyrimidine metabolism
73Cathy Ann Rouze SpigarelliM.S.1993Carlo Tamburro, M.D.An investigation of nickel toxicity: an invitro study with  escherichia coli
72Di ChenPh.D.1992William M. Pierce Jr., Ph.D.Effects of zinc on bone metabolism
71Qusai Al-MahasnehM.S.1991George R. Rodgers, M.D., Ph.D.The role of activated charcoal in the treatment of acute arsenic poisoning: an in vivo study
70Mary Kathleen King KaysingerPh.D.1991William M. Pierce Jr., Ph.D.Regulation of bone prolyl-4-hydroxylase activity by 2-oxoglutarate
69Rachelle J. Sells GalvinPh.D.1990Warren K. Ramp, Ph.D.Effects of prolyhydroxylase inhibitors extracted from tobacco on bone collagen synthesis
68Mordechai SharirPh.D.1990William M. Pierce Jr., Ph.D.Novel thiadiazole sulfonamide carbonic anhydrase inhibitors as topically effective ocular hypotensive agents (glaucoma)
67Chong ZhangPh.D.1990Guandershan Thind, M.D.Effects of cadmium on the renal and skeletal muscle microcirculation in rats
66James M. Joly IIPh.D.1989Walter M. Williams, M.D., Ph.D.Elimination of 5-ethylpyridimidines and 5-methylpyrimidines by the isolated perfused rat liver
65Mark J. KlanPh.D.1988Donald E. Nerland, Ph.D.Microsomal carbinol dehydrogenase: isolation and possible role in xenobiotic toxicity
64Karl G. CsakyPh.D.1987Walter M. Williams, M.D., Ph.D.Metabolism of fluorodeoxyuridine by the isolated perfused rat liver
63Charles R. Ashby, Jr.Ph.D.1987Laurence A. Carr, Ph.D.Alteration of serotoninergic mechanisms in premenstrual syndrome (PMS)
62Elizabeth D. DunlapPh.D.1987Michael A. Pfeifer, M.D.Biochemical and physiological change associated with diabetes in the diabetic BB rat
61Fu-Hsiung LinPh.D.1987Walter M. Williams, M.D., Ph.D.Fluorodeoxyuridine catabolism by isolated intestinal and tumor cells
60John J. SchlagerPh.D.1987Harrell E. Hurst, Ph.D.Elimination of acetaminophen by the isolated perfused rat liver in the absence and presence of ethanol
59Michael S. WellsPh.D.1986Donald E. Nerland, Ph.D.Benzene metabolism and toxicity after inhalation exposure: analysis at steady-state
58Donald E. WaltersPh.D.1986Laurence A. Carr, Ph.D.Neurochemical development in the rat following perinatal exposure to marihuana
57Frank LaCretaPh.D.1986Walter M. Williams, M.D., Ph.D.Effect of nucleoside phosphorylase inhibitors on hepatic fluoropyridmidine elimination
56Ching-hsuen ChuM.S.1986Warren K. Ramp, Ph.D.The interrelationships of calcium release and glucose metabolism in bone
55Cynthia L. WabnerPh.D.1986Theresa S. Chen, Ph.D.Aging changes n renal function and structure
54Barbour S. WarrenPh.D.1985Walter M. Williams, M.D., Ph.D.Fluoropyrimidine disposition: dose and flow dependence
53Nancy A. MumaPh.D.1985Peter P. Rowell, Ph.D.Pharmacological, biochemical, morphological and behavioral effects on long-term choline and lecithin administration on the aged central cholinergic nervous system
52Brian J. LukeyPh.D.1985Harrell E. Hurst, Ph.D.Predictors of plasma and tissue concentrations of nortriptyline and 10-OH metabolites
51James A. BlankPh.D.1985Leonard C. Waite, Ph.D.Calcium metabolism by the avian embryo
50Michael J. KelleyPh.D.1984Theresa S. Chen, Ph.D.Effects of 5-Thio-D-glucose on hexose transport and metabolism
49Sayed DaoudPh.D.1984Kee Chang Huang, M.D., Ph.D.Adriamycin: pharmacological studies on liver, kidney and heart
48Brian J. LukeyM.S.1983Harrell E. Hurst, Ph.D.Sources of variability in plasma concentration measurements of nortriptyline and 10-hydroxylated metabolites
47David R. JonesPh.D.1983Harrell E. Hurst, Ph.D.Tissue distribution and toxicokinetics of nortriptyline
46Michael W. McWilliamsM.S.1983Theresa S. Chen, Ph.D.Preservation of microsomal enzyme activities in rat liver by WR-2721 following gamma-irradiation
45Mostafa Z. BadrPh.D.1983Thomas G. Scharff, Ph.D.Cellular penetration and toxicity of benzoic and salicyclic acids
44Christopher J. KemperPh.D.1983Donald E. Nerland, Ph.D.Studies concerning the metabolism and kinetics of benzene in the mouse
43Adrian B. VanBakelPh.D.1983William J. Waddell, M.D.Renal vascular activity of bis substituted (3,4-dimethoxybenzyl)cycloalkylamine and heterocyclic amine hydrochlorides
42Lois E. BolcsakPh.D.1982Donald E. Nerland, Ph.D.Benzene toxicity:emphasis on cytosolic dihydrodiol dehydrogenases
41Stanley D. ErkPh.D.1982Charles H. Jarboe, Ph.D.Toxicokinetic study of 1,2-propanediol dinitrate (PGDN) in the dog
40Michael P. LachancePh.D.1982William J. Waddell, M.D.Whole-body localization of caffeine in the mouse
39Mahmood H. Al-WathiquiPh.D.1982William J. Waddell, M.D.Effects of total parenteral nutrition on pharmacokinetics of drugs
38Sonia R. TellerPh.D.1982Charles H. Jarboe, Ph.D.Synthesis and peripheral cardiovascularization of cis- and trans-2-(3,4-dimethoxybenzyl)cycloalkylamine hydrochlorides
37David R. JonesM.S.1981Harrell E. Hurst, Ph.D.Human pharmacokinetics of clovoxamine
36William M. Pierce, Jr.Ph.D.1981Leonard C. Waite, Ph.D.Effects of heterocyclic sulfonamides on bone metabolism
35Steven M. LeventerPh.D.1981Peter P. Rowell, Ph.D.Investigations of the human placental cholinergic system
34Raymond M. DavidPh.D.1981Donald E. Nerland, Ph.D.Induction of hepatic glutathione S-transferase by ethanol
33David C. MayPh.D.1981Charles H. Jarboe, Ph.D.Some aspects of rabbit and human methylxanthine pharmacokinetics
32Maralyn E. KaufmanPh.D.1980Kee Chang Huang, M.D., Ph.D.Effects of glucagon on the electrical and transport properties of the intestine
31Harriet TobiasPh.D.1980Laurence A. Carr, Ph.D.The interaction of gonadal steroids and catecholamine neurons on release of luteinizing hormone and prolactin
30Margaret M. SchweriPh.D.1980Laurence A. Carr, Ph.D.Inhibition of monoamine synthesis of cycloheximide and anisomycin: possible mechanisms of action
29Gary E. DuncanPh.D.1980Peter P. Rowell, Ph.D.The subcellular distribution and release of newly synthesized acetylcholine in rat cerebral cortical synaptosomes
28Barbara WenzakPh.D.1980Kee Chang Huang, M.D., Ph.D.The renal excretion of methotrexate
27Susan M. WehryM.S.1979Laurence A. Carr, Ph.D.The effects of amnesic agents and d-amphetamine on brain catecholamines in two mouse strains
26Michael J. BannonM.S.1978Charles H. Jarboe, Ph.D.Central nervous system action of 2,5-bis-(3,4-dimethoxybenzyl)cyclopentyl amine, a peripheral dopamine blocking agent
25Mark D. LineberryPh.D.1978Leonard C. Waite, Ph.D.Effects of carbonic anhydrase inhibitors on calcium metabolism
24Paul H. LungrenM.S.1978Laurence A. Carr, Ph.D.The effects of anisomycin and central nervous stimulants on brain catecholamine synthesis
23Andrew M. ConnorM.S.1975Curtis A. Sigdestad, Ph.D.The enhancement of gamma radiation by procarbazine hydrochloride
22Aaron E. LucasM.S.1974John A. Nicholson, Ph.D.The effects of acute and chronic morphine administration on the cardiovascular system of the dog
21Chung Sim KimM.S.1973Kee Chang Huang, M.D., Ph.D.A cerebroventricular perfusion technique for studying L-tryrosine transport into the ventricle
20James A. SchaeferM.S.1973Charles H. Jarboe, Ph.D.Some aspects of S-(-)-nicotine biochemorphology
19Yun-Lai ChanPh.D.1971Kee Chang Huang, M.D., Ph.D.Microperfusion and micropuncture studies of renal tubular transport of tryptophan derivatives
18Theresa S.T. ChenPh.D.1971Kee Chang Huang, M.D., Ph.D.Ion transport across the intestinal mucosa of fish
17Walter M. WilliamsPh.D.1970Kee Chang Huang, M.D., Ph.D.Structural specificity in the renal tubular transport of tryptophan derivatives
16George P. CastenPh.D.1969Thomas G. Scharff, Ph.D.Hexose-induced delay of hexose monophosphate fermentation in dialysed yeast extract
15Gloria D. SellsPh.D.1969Kee Chang Huang, M.D., Ph.D.Studies of the development of intestinal transport
14John A. NicholsonPh.D.1969Charles H. Jarboe, Ph.D.Pharmacological properties of viburnum
13Patrick E. BentleyPh.D.1968Peter K. Knoefel, M.D.Liberation of histamine as a mechanism of the toxic action of radiopaque diagnostic agents
12Kenneth L. BaileyPh.D.1968Peter K. Knoefel, M.D.Hippuric acid secretion in the mammalian kidney
11Karimullah Abd ZirviPh.D.1968Charles H. Jarboe, Ph.D.Centrally active imides and amides of certain cyclobutanecarboxylic acids
10Raymond L. WoosleyPh.D.1967Kee Chang Huang, M.D., Ph.D.Renal tubular transport of hexoses
9David N. JohnsonM.S.1966Richard P. Smith, Ph.D.The sympathetic innervation of the rabbit seminal vesicle
8Mahmoud OskouiPh.D.1965Peter K. Knoefel, M.D.Nephrotic action of a synthetic plastic material and some of its constituents
7Lin Min ChenM.S.1965Paul G. LeFevre, Ph.D.Reactions of red cell sugar transport system with non-transported analogues
6Robert L. MoffittPh.D.1964Thomas G. Scharff, Ph.D.Reinvestigation of certain aspects of fermentation in yeast extracts
5David LingM.S.1964Kee Chang Huang, M.D., Ph.D.Biliary excretion of organic acids
4Alan R. KolberPh.D.1964Paul G. LeFevre, Ph.D.Evidence for carrier-mediated transport of monosaccharides in the Ehrlich ascitis tumor cell
3Linda CohenM.S.1963Kee Chang Huang, M.D., Ph.D.Intestinal absorption of tryptophan and its derivatives
2Hubert J. WolfeM.S.1959Kee Chang Huang, M.D., Ph.D.The metabolism of the aminobenzoic acids in the adult and embryonic gallus domesticus
1James W. FisherPh.D.1958Peter K. Knoefel, M.D.The influence of the adrenocortical hormones on cobalt polycythemia